Analyst Expects Sarepta Therapeutics Inc (NASDAQ: SRPT) To Make Big Moves

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Sarepta Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Sarepta Therapeutics Inc is $7.41B. A total of 1.87 million shares were traded on the day, compared to an average of 1.22M shares.

In the most recent transaction, Nicaise Claude sold 2,491 shares of SRPT for 99.64 per share on Mar 12 ’25. After the transaction, the Director now owns 27,812 company shares. In a previous transaction on Mar 12 ’25, Nicaise Claude bought 2,491 shares at 99.65 per share.

Among the insiders who sold shares, Wigzell Hans Lennart Rudolf disposed of 10,500 shares on Dec 12 ’24 at a per-share price of $124.84. This resulted in the Director holding 22,840 shares of SRPT after the transaction. In another insider transaction, Wigzell Hans Lennart Rudolf bought 10,500 shares at $124.80 per share on Dec 12 ’24.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SRPT has a high of $173.25 and a low of $73.05.

As of this writing, SRPT has an earnings estimate of $0.59 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $2.84 per share and a lower estimate of -$2.99.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $15.77, while its Total Shareholder’s Equity was $928.01M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.55.

Most Popular

Related Posts